Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 493 to 499 of 499 entries
Sorted by: Best Match Show Resources per page
Size-controlled bimodal .

Science and technology of advanced materials

Okubo K, Takeda R, Murayama S, Umezawa M, Kamimura M, Osada K, Aoki I, Soga K.
PMID: 33762891
Sci Technol Adv Mater. 2021 Mar 10;22(1):160-172. doi: 10.1080/14686996.2021.1887712.

Rare-earth-doped nanoparticles (NPs), such as NaGdF

Cite
Okubo K, Takeda R, Murayama S, et al. Size-controlled bimodal . Sci Technol Adv Mater. 2021;22(1):160-172doi: 10.1080/14686996.2021.1887712.
Okubo, K., Takeda, R., Murayama, S., Umezawa, M., Kamimura, M., Osada, K., Aoki, I., & Soga, K. (2021). Size-controlled bimodal . Science and technology of advanced materials, 22(1), 160-172. https://doi.org/10.1080/14686996.2021.1887712
Okubo, Kyohei, et al. "Size-controlled bimodal ." Science and technology of advanced materials vol. 22,1 (2021): 160-172. doi: https://doi.org/10.1080/14686996.2021.1887712
Okubo K, Takeda R, Murayama S, Umezawa M, Kamimura M, Osada K, Aoki I, Soga K. Size-controlled bimodal . Sci Technol Adv Mater. 2021 Mar 10;22(1):160-172. doi: 10.1080/14686996.2021.1887712. PMID: 33762891; PMCID: PMC7952065.
Copy Download .nbib Format: NLM
Research and Development Strategy for Future Embryonic Stem Cell-Based Therapy in Japan.

JMA journal

Umezawa A, Sato Y, Kusakawa S, Amagase R, Akutsu H, Nakamura K, Kasahara M, Matsubara Y, Igarashi T.
PMID: 33225099
JMA J. 2020 Oct 15;3(4):287-294. doi: 10.31662/jmaj.2018-0029. Epub 2020 Sep 23.

Herewith, we review an updated progress of regenerative medical products using human embryonic stem cells (ESCs) in Japan. Two groups from Kyoto University and the National Center for Child Health and Development (NCCHD) established a novel derivation/cultivation system of...

Cite
Umezawa A, Sato Y, Kusakawa S, et al. Research and Development Strategy for Future Embryonic Stem Cell-Based Therapy in Japan. JMA J. 2020;3(4):287-294doi: 10.31662/jmaj.2018-0029.
Umezawa, A., Sato, Y., Kusakawa, S., Amagase, R., Akutsu, H., Nakamura, K., Kasahara, M., Matsubara, Y., & Igarashi, T. (2020). Research and Development Strategy for Future Embryonic Stem Cell-Based Therapy in Japan. JMA journal, 3(4), 287-294. https://doi.org/10.31662/jmaj.2018-0029
Umezawa, Akihiro, et al. "Research and Development Strategy for Future Embryonic Stem Cell-Based Therapy in Japan." JMA journal vol. 3,4 (2020): 287-294. doi: https://doi.org/10.31662/jmaj.2018-0029
Umezawa A, Sato Y, Kusakawa S, Amagase R, Akutsu H, Nakamura K, Kasahara M, Matsubara Y, Igarashi T. Research and Development Strategy for Future Embryonic Stem Cell-Based Therapy in Japan. JMA J. 2020 Oct 15;3(4):287-294. doi: 10.31662/jmaj.2018-0029. Epub 2020 Sep 23. PMID: 33225099; PMCID: PMC7676987.
Copy Download .nbib Format: NLM
Correction to "Synthesis of (+)-Muconin via Diastereoselective Oxypalladation".

The Journal of organic chemistry

Sugimoto M, Nosho S, Hikosaka G, Hattori Y, Umezawa K, Kawamura A, Makabe H.
PMID: 33840188
J Org Chem. 2021 May 07;86(9):7019. doi: 10.1021/acs.joc.1c00691. Epub 2021 Apr 11.

No abstract available.

Cite
Sugimoto M, Nosho S, Hikosaka G, et al. Correction to "Synthesis of (+)-Muconin via Diastereoselective Oxypalladation". J Org Chem. 2021;86(9):7019doi: 10.1021/acs.joc.1c00691.
Sugimoto, M., Nosho, S., Hikosaka, G., Hattori, Y., Umezawa, K., Kawamura, A., & Makabe, H. (2021). Correction to "Synthesis of (+)-Muconin via Diastereoselective Oxypalladation". The Journal of organic chemistry, 86(9), 7019. https://doi.org/10.1021/acs.joc.1c00691
Sugimoto, Makoto, et al. "Correction to "Synthesis of (+)-Muconin via Diastereoselective Oxypalladation"." The Journal of organic chemistry vol. 86,9 (2021): 7019. doi: https://doi.org/10.1021/acs.joc.1c00691
Sugimoto M, Nosho S, Hikosaka G, Hattori Y, Umezawa K, Kawamura A, Makabe H. Correction to "Synthesis of (+)-Muconin via Diastereoselective Oxypalladation". J Org Chem. 2021 May 07;86(9):7019. doi: 10.1021/acs.joc.1c00691. Epub 2021 Apr 11. PMID: 33840188.
Copy Download .nbib Format: NLM
Atlantoaxial Rotatory Fixation after Microtia Reconstruction Surgery.

Plastic and reconstructive surgery. Global open

Takada G, Asato H, Umekawa K, Kurabayashi T, Sasaki S, Kaji N.
PMID: 34476155
Plast Reconstr Surg Glob Open. 2021 Aug 23;9(8):e3760. doi: 10.1097/GOX.0000000000003760. eCollection 2021 Aug.

Nontraumatic atlantoaxial rotatory fixation after microtia reconstruction surgery is a rare complication. Intraoperative cervical hyperextension and/or excessive rotation and postoperative inflammation have been reported as causes of atlantoaxial rotatory fixation. We herein describe cases of atlantoaxial rotatory fixation after...

Cite
Takada G, Asato H, Umekawa K, et al. Atlantoaxial Rotatory Fixation after Microtia Reconstruction Surgery. Plast Reconstr Surg Glob Open. 2021;9(8):e3760doi: 10.1097/GOX.0000000000003760.
Takada, G., Asato, H., Umekawa, K., Kurabayashi, T., Sasaki, S., & Kaji, N. (2021). Atlantoaxial Rotatory Fixation after Microtia Reconstruction Surgery. Plastic and reconstructive surgery. Global open, 9(8), e3760. https://doi.org/10.1097/GOX.0000000000003760
Takada, Goro, et al. "Atlantoaxial Rotatory Fixation after Microtia Reconstruction Surgery." Plastic and reconstructive surgery. Global open vol. 9,8 (2021): e3760. doi: https://doi.org/10.1097/GOX.0000000000003760
Takada G, Asato H, Umekawa K, Kurabayashi T, Sasaki S, Kaji N. Atlantoaxial Rotatory Fixation after Microtia Reconstruction Surgery. Plast Reconstr Surg Glob Open. 2021 Aug 23;9(8):e3760. doi: 10.1097/GOX.0000000000003760. eCollection 2021 Aug. PMID: 34476155; PMCID: PMC8382324.
Copy Download .nbib Format: NLM
Prenatal enzyme replacement therapy for .

Regenerative therapy

Hasegawa A, Nakamura-Takahashi A, Kasahara M, Saso N, Narisawa S, Millán JL, Samura O, Sago H, Okamoto A, Umezawa A.
PMID: 34277899
Regen Ther. 2021 Jul 05;18:168-175. doi: 10.1016/j.reth.2021.06.002. eCollection 2021 Dec.

Hypophosphatasia (HPP) is a congenital skeletal disease. Impairment of bone mineralization and seizures are due to a deficiency of tissue-nonspecific alkaline phosphatase (TNAP). Enzyme replacement therapy (ERT) is available as a highly successful treatment for pediatric-onset HPP. However, the...

Cite
Hasegawa A, Nakamura-Takahashi A, Kasahara M, et al. Prenatal enzyme replacement therapy for . Regen Ther. 2021;18:168-175doi: 10.1016/j.reth.2021.06.002.
Hasegawa, A., Nakamura-Takahashi, A., Kasahara, M., Saso, N., Narisawa, S., Millán, J. L., Samura, O., Sago, H., Okamoto, A., & Umezawa, A. (2021). Prenatal enzyme replacement therapy for . Regenerative therapy, 18168-175. https://doi.org/10.1016/j.reth.2021.06.002
Hasegawa, Akihiro, et al. "Prenatal enzyme replacement therapy for ." Regenerative therapy vol. 18 (2021): 168-175. doi: https://doi.org/10.1016/j.reth.2021.06.002
Hasegawa A, Nakamura-Takahashi A, Kasahara M, Saso N, Narisawa S, Millán JL, Samura O, Sago H, Okamoto A, Umezawa A. Prenatal enzyme replacement therapy for . Regen Ther. 2021 Jul 05;18:168-175. doi: 10.1016/j.reth.2021.06.002. eCollection 2021 Dec. PMID: 34277899; PMCID: PMC8267436.
Copy Download .nbib Format: NLM
Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers.

Journal of gastroenterology and hepatology

Sasaki Y, Abe Y, Nishise S, Yagi M, Mizumoto N, Kon T, Onozato Y, Sakai T, Umehara M, Ito M, Ueno Y.
PMID: 34859497
J Gastroenterol Hepatol. 2021 Dec 03; doi: 10.1111/jgh.15748. Epub 2021 Dec 03.

BACKGROUND AND AIM: Obesity, insulin resistance, and metabolic alterations increase the risk of colorectal cancer and adenoma (CRA). Non-alcoholic fatty liver disease (NAFLD) or pancreatic disease (NAFPD) shares many risk factors with CRA that may have significant roles in...

Cite
Sasaki Y, Abe Y, Nishise S, et al. Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers. J Gastroenterol Hepatol. 2021;doi: 10.1111/jgh.15748.
Sasaki, Y., Abe, Y., Nishise, S., Yagi, M., Mizumoto, N., Kon, T., Onozato, Y., Sakai, T., Umehara, M., Ito, M., & Ueno, Y. (2021). Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers. Journal of gastroenterology and hepatology, . https://doi.org/10.1111/jgh.15748
Sasaki, Yu, et al. "Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers." Journal of gastroenterology and hepatology vol. (2021). doi: https://doi.org/10.1111/jgh.15748
Sasaki Y, Abe Y, Nishise S, Yagi M, Mizumoto N, Kon T, Onozato Y, Sakai T, Umehara M, Ito M, Ueno Y. Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers. J Gastroenterol Hepatol. 2021 Dec 03; doi: 10.1111/jgh.15748. Epub 2021 Dec 03. PMID: 34859497.
Copy Download .nbib Format: NLM
Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Fukushima K, Futatsugi A, Maekawa M, Naito S, Okada A, Sugioka N.
PMID: 34999374
Biomed Pharmacother. 2022 Jan 06;147:112619. doi: 10.1016/j.biopha.2022.112619. Epub 2022 Jan 06.

To prevent cisplatin (CDDP)-induced nephrotoxicity, co-treatment with massive hydration is essential for its clinical use. However, some patients are ineligible for this treatment. For such patients, a split dose of CDDP has been suggested as an alternative strategy. This...

Cite
Fukushima K, Futatsugi A, Maekawa M, et al. Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats. Biomed Pharmacother. 2022;147:112619doi: 10.1016/j.biopha.2022.112619.
Fukushima, K., Futatsugi, A., Maekawa, M., Naito, S., Okada, A., & Sugioka, N. (2022). Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 147112619. https://doi.org/10.1016/j.biopha.2022.112619
Fukushima, Keizo, et al. "Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 147 (2022): 112619. doi: https://doi.org/10.1016/j.biopha.2022.112619
Fukushima K, Futatsugi A, Maekawa M, Naito S, Okada A, Sugioka N. Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats. Biomed Pharmacother. 2022 Jan 06;147:112619. doi: 10.1016/j.biopha.2022.112619. Epub 2022 Jan 06. PMID: 34999374.
Copy Download .nbib Format: NLM
Showing 493 to 499 of 499 entries